InVitro Received Final Approval of Ocular Irritection


InVitro International and its Italian in vitro testing partner, INT.E.G.RA, received final acceptance of Ocular Irritection. This stems from the Organization for Economic Common Development (OECD) Expert Group on Skin and Eye Irritation Test Methods, which held its annual meeting in November 2017 in Paris. The OECD is viewed as an international regulatory authority on in vitro test methods.

Moving forward, InVitro is composing a Test Guideline (TG) document for submission to the OECD to show its test method is clear and available to all laboratories interested in using the Ocular Irritection test.

“This nearly global level of regulatory support for a non-mammalian (plant protein) test technology not only means much to InVitro, but also could possibly encourage more innovative in vitro test methods to be developed as well. We continue to be very enthusiastic about the future for non-animal testing on a global basis,” said W. Richard Ulmer, CEO and president, InVitro. “Ocular Irritection is the only such method with OECD acceptance which can be shipped anywhere in the world with significant remaining shelf life for its laboratory users.”

More in Companies